Bailly, C.; Cléry, P.-F.; Faivre-Chauvet, A.; Bourgeois, M.; Guérard, F.; Haddad, F.; Barbet, J.; Chérel, M.; Kraeber-Bodéré, F.; Carlier, T.;
et al. Immuno-PET for Clinical Theranostic Approaches. Int. J. Mol. Sci. 2017, 18, 57.
https://doi.org/10.3390/ijms18010057
AMA Style
Bailly C, Cléry P-F, Faivre-Chauvet A, Bourgeois M, Guérard F, Haddad F, Barbet J, Chérel M, Kraeber-Bodéré F, Carlier T,
et al. Immuno-PET for Clinical Theranostic Approaches. International Journal of Molecular Sciences. 2017; 18(1):57.
https://doi.org/10.3390/ijms18010057
Chicago/Turabian Style
Bailly, Clément, Pierre-François Cléry, Alain Faivre-Chauvet, Mickael Bourgeois, François Guérard, Ferid Haddad, Jacques Barbet, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier,
and et al. 2017. "Immuno-PET for Clinical Theranostic Approaches" International Journal of Molecular Sciences 18, no. 1: 57.
https://doi.org/10.3390/ijms18010057
APA Style
Bailly, C., Cléry, P.-F., Faivre-Chauvet, A., Bourgeois, M., Guérard, F., Haddad, F., Barbet, J., Chérel, M., Kraeber-Bodéré, F., Carlier, T., & Bodet-Milin, C.
(2017). Immuno-PET for Clinical Theranostic Approaches. International Journal of Molecular Sciences, 18(1), 57.
https://doi.org/10.3390/ijms18010057